- Home
- RCG vs ICU Comparison
RCG vs ICU Comparison
Compare RCG & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCG
- ICU
- Stock Information
- Founded
- RCG 1994
- ICU 2018
- Country
- RCG United States
- ICU United States
- Employees
- RCG N/A
- ICU N/A
- Industry
- RCG Investment Managers
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- RCG Finance
- ICU Health Care
- Exchange
- RCG Nasdaq
- ICU Nasdaq
- Market Cap
- RCG 18.2M
- ICU 15.9M
- IPO Year
- RCG N/A
- ICU N/A
- Fundamental
- Price
- RCG $2.66
- ICU $0.38
- Analyst Decision
- RCG
- ICU
- Analyst Count
- RCG 0
- ICU 0
- Target Price
- RCG N/A
- ICU N/A
- AVG Volume (30 Days)
- RCG 5.9K
- ICU 829.3K
- Earning Date
- RCG 01-01-0001
- ICU 11-13-2025
- Dividend Yield
- RCG 0.98%
- ICU N/A
- EPS Growth
- RCG N/A
- ICU N/A
- EPS
- RCG N/A
- ICU N/A
- Revenue
- RCG N/A
- ICU $766,000.00
- Revenue This Year
- RCG N/A
- ICU $820.00
- Revenue Next Year
- RCG N/A
- ICU $63.37
- P/E Ratio
- RCG N/A
- ICU N/A
- Revenue Growth
- RCG N/A
- ICU N/A
- 52 Week Low
- RCG $1.52
- ICU $0.31
- 52 Week High
- RCG $1.90
- ICU $3.07
- Technical
- Relative Strength Index (RSI)
- RCG 59.49
- ICU 27.17
- Support Level
- RCG $2.50
- ICU $0.47
- Resistance Level
- RCG $2.68
- ICU $0.52
- Average True Range (ATR)
- RCG 0.06
- ICU 0.05
- MACD
- RCG 0.01
- ICU -0.01
- Stochastic Oscillator
- RCG 94.38
- ICU 7.99
About RCG RENN Fund Inc
RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.